TRAVERE THERAPEUTICS

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark TRAVERE THERAPEUTICS was filed as Word mark on 06/25/2020 at the World Intellectual Property Organization.

Trademark Details Last update: January 12, 2023

Trademark form Word mark
File reference 1543170
Countries Australia Canada Switzerland China Colombia European Community United Kingdom Israel India Iceland Japan South Korea Mexico Norway New Zealand Russia Singapore Turkey
Base trademark US No. 88758429, January 14, 2020
Application date June 25, 2020
Expiration date June 25, 2030

Trademark owner

3611 Valley Centre Drive, Suite 300
San Diego CA 92130
US

Trademark representatives

701 Fifth Avenue, Suite 5400 Seattle WA 98104 US

goods and services

05 Pharmaceutical preparations for the prevention of liver diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the prevention of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the prevention of monogenic diseases and disorders; pharmaceutical preparations for the treatment of monogenic diseases and disorders; pharmaceutical preparations for the prevention of metabolic diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders; therapeutic preparations for the prevention of liver diseases and disorders; therapeutic preparations for the treatment of liver diseases and disorders; therapeutic preparations for the prevention of kidney diseases and disorders; therapeutic preparations for the treatment of kidney diseases and disorders; therapeutic preparations for the prevention of central nervous system diseases and disorders; therapeutic preparations for the treatment of central nervous system diseases and disorders; therapeutic preparations for the prevention of monogenic diseases and disorders; therapeutic preparations for the treatment of monogenic diseases and disorders; therapeutic preparations for the prevention of metabolic diseases and disorders; therapeutic preparations for the treatment of metabolic diseases and disorders

Trademark history

Date Document number Area Entry
December 14, 2022 2023/2 Gaz CA RAW: Rule 18ter(2)(ii) GP following a provisional refusal
May 31, 2022 2022/22 Gaz MX Rejection
February 22, 2022 2022/8 Gaz IS Rejection
November 26, 2021 2021/49 Gaz CA Rejection
September 23, 2021 2021/38 Gaz CH Rejection
September 23, 2021 2021/38 Gaz NO Rejection
August 24, 2021 2021/35 Gaz KR Rejection
July 29, 2021 2021/30 Gaz JP Rejection
July 23, 2021 2021/39 Gaz CO RAW: Rule 18ter(2)(i) GP following a provisional refusal
July 8, 2021 2021/30 Gaz IL RAW: Rule 18ter(2)(i) GP following a provisional refusal
March 19, 2021 2021/12 Gaz NZ Rejection
February 15, 2021 2021/7 Gaz IN Rejection
January 31, 2021 2021/6 Gaz CO Rejection
January 1, 2021 2021/1 Gaz SG Rejection
December 23, 2020 2020/53 Gaz TR Rejection
December 22, 2020 2020/52 Gaz AU Rejection
December 16, 2020 2020/51 Gaz EM Rejection
November 27, 2020 2020/49 Gaz RU Rejection
November 26, 2020 2020/48 Gaz CN Rejection
November 11, 2020 2020/46 Gaz GB Rejection
November 4, 2020 2020/46 Gaz IL Rejection
October 9, 2020 2020/43 Gaz US Correction
June 25, 2020 2020/29 Gaz US Registration

ID: 141543170